Tom F. Lue MDProfessor and Vice-Chair of Urology and Emil Tanagho Endowed Chair in Clinical Urology, University of California San Francisco School of Medicine, San Francisco, California
Dr. Tom F. Lue graduated with highest honors from Kaohsiung Medical College in Taiwan in 1972. After completing urology residency at SUNY Downstate in 1981, he received a Valentine Fellowship from the New York Academy of Medicine to study neurourology at the University of California, San Francisco (UCSF). He is now Professor and Vice-Chair of Urology at UCSF, Emil Tanagho Endowed Chair in Clinical Urology, and the founder of the Knuppe Molecular Urology Laboratory. He is a recipient of NIH MERIT Award for his translational research in penile physiology and erectile dysfunction. His team discovered the anatomical mechanism of venous compression during penile erection, published the first article implicating TGF beta in the formation of Peyronie’s plaque, and developed the animal models for the study of Peyronie’s disease and stress urinary incontinence. He has developed four diagnostic tests for erectile dysfunction: the penile injection and stimulation test, the duplex ultrasound test for penile arterial flow, pharmacologic cavernosography for venous leakage, and the use of duplex ultrasound to diagnose priapism. He also developed seven new surgical procedures for Peyronie’s disease, priapism and erectile dysfunction. He has been the recipient of the American Urological Association's Gold Cystoscope Award and the American Foundation of Urological diseases’ Most Innovative Researcher Award. He Chaired the International Consultation on Sexual Medicine held in Paris in July 2003 serving as lead author of its published proceedings. He was the honorary president of the same meeting in Paris in July, 2009.
Dr. Lue's current basic science research projects involve the development of a non-invasive progenitor cell therapy for various degenerative diseases.
Besides being listed in The Best Doctors in America and America’s Top Doctors for many years, he was named one of the 8 top doctors for men by Men’s Health Magazine in 2003. He has published more than 400 peer reviewed articles and more than 100 book chapters. His research team has trained more than 70 postgraduate doctors from many countries.
Dr. Lue is a consultant for Pfizer, Eli Lilly, Auxillium and American Medical Systems.
Recent Contributions to PracticeUpdate:
- Risk of Priapism With Oral PDE5 Inhibitors
- Different Dose Regimens of Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction
- Complications and Approaches to Collagenase Clostridium histolyticum for Peyronie's Disease
- Complications Following Intralesional Injection Therapy With Collagenase C. histolyticum for Peyronie's Disease
- Intralesional Collagenase Clostridium histolyticum Injection for Peyronie's Disease
- Low-Intensity Extracorporeal Shockwave Therapy and Erectile Dysfunction
- MY APPROACH to Priapism in Patients With Sickle Cell Disease
- Can Sexual Intercourse Be an Alternative Therapy for Distal Ureteral Stones? A Prospective, Randomized, Controlled Study
- European Association of Urology Guidelines on Priapism